Market closed·Syncing…
Market closed · Close · 19 Nov

Entero Healthcare Solutions Limited ENTEROshare price and chart

Entero Healthcare Solutions closed at ₹1,973.00 on 19 November 2026, down 0.65% on the day. The 52-week range is ₹944.00 to ₹2,137.60.

₹1,973.00The price one share last traded at, in rupees.▼ 0.65% · ₹12.91
52-wk low ₹94486% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹2,138

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on ENTERO

Real prices, every charge counted. Pick one or write your own.
What Entero Healthcare Solutions Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Entero Healthcare Solutions and its subsidiaries distribute and market pharmaceuticals, surgical and other healthcare products to other businesses, which provide all of its turnover, through 137 locations across 21 states.

1
1Sector

Retailing

2
2What it sells

Pharmaceutical and surgical product distribution

3
3Who buys it

Pharmacies, hospitals, healthcare businesses

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
65.3Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
45.1%Near average
today 45.1%20d avg 43.9%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+13.4%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+45.3%1 monthHow much the share price has changed over the period.+32.8%3 monthsHow much the share price has changed over the period.+42.3%1 yearHow much the share price has changed over the period.+72.0%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.51.5%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹8,587 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.61.6xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.8.3%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.4.82xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.10.7%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.33.1xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.42xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.0.4%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Retailing · 59 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.61.6vs 26.3 median
Cheapest: VMOBILE 5.08Priciest: ETERNAL 679.35
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.2.51%vs 3.19% median
Lowest: URBANCO -24.39%Highest: NAUKRI 63.7%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.32.85%vs 14.88% median
Lowest: CRIZAC -36.72%Highest: WOMANCART 125.8%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 4 Nov 2026), sales rose 32.9% from a year earlier to ₹2,087 cr and profit rose 66.0% to ₹60.7 cr.

Worth watching
  • Return on equity stayed under 10% from FY24 to FY26 (highest 8.3%).
Also changed
  • Foreign institutions cut their holding by 11.4 points over 5 quarters (17.20% to 5.77%).
  • Domestic institutions raised their holding by 11.0 points over 5 quarters (10.18% to 21.16%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 12 results, the share rose on 6 and fell on 6, and moved by 3% or more on 8.

+11%
-11%
Q1 FY25Q4 FY25Q3 FY26Q2 FY27

Q2 FY27: results filed 4 Nov 2026. The share went from its close on 3 Nov 2026 to its close on 5 Nov 2026 +10.92%.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
+82.0%over the last year
1 yr
+82.0%

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
52.4%promoter holding, as of 2026-09-30+0.0 pts since 2024
Promoter share since listing
2024-0252.4% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
52.4%
21.2%
20.7%
Promoter52.4%Foreign (FII)5.8%Domestic (DII)21.2%Public & others20.7%
Who is buying, who is leavingJun 25 to Sep 26
Promoter52.4%steady
Foreign (FII)5.8%-11.4 pts
Domestic (DII)21.2%+11.0 pts

Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates12-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about Transcript

Copy of Newspaper Publication06-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited Financial Results for the quarter and half year ended September 30, 2026

Analysts/Institutional Investor Meet/Con. Call Updates05-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording

Analysts/Institutional Investor Meet/Con. Call Updates05-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording

General Updates04-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about General Updates

Investor Presentation04-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation

ESOP/ESOS/ESPS04-Nov-2026

Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 49712 Options.

Outcome of Board Meeting04-Nov-2026

Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Analysts/Institutional Investor Meet/Con. Call Updates28-Oct-2026

Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet

Certificate under SEBI (Depositories and Participants) Regulations, 201813-Oct-2026

Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

ESOP/ESOS/ESPS12-Oct-2026

Entero Healthcare Solutions Limited has informed the Exchange regarding allotment of Equity Shares upon exercise of stock options under the Entero Employee Stock Option Plan 2023

Trading Window23-Sep-2026

Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Analysts/Institutional Investor Meet/Con. Call Updates22-Sep-2026

Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet

General Updates12-Sep-2026

Entero Healthcare Solutions Limited has informed the Exchange about General Updates

Analysts/Institutional Investor Meet/Con. Call Updates24-Aug-2026

Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet

Backtest idea · ENTEROMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTEROLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTEROSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on ENTERO
Your own ideaWrite a rule for ENTERO in plain English“Buy ENTERO when …”
Start writing
Buy the dip on ENTEROBuy when RSI(14) drops below 30
52-week high breakout on ENTEROBuy when closes at a 52-week high
Golden cross on ENTEROBuy when 50-day EMA crosses above 200-day
Stochastic oversold on ENTEROBuy when stochastic %K drops below 20
Pullback in an uptrend on ENTEROBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹8,587 cr
Larger than 75% of 59 peers
sector middle ₹1,512 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
61.6x
Higher than 83% of 36 peers
sector middle 26.3x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
4.8x
Higher than 63% of 52 peers
sector middle 3.2x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
8.3%
Lower than 56% of 41 peers
sector middle 10.2%
FY24 2.4%FY26 8.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
10.7%
Lower than 59% of 49 peers
sector middle 13.3%
FY24 5.3%FY26 10.7%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.42
Higher than 73% of 52 peers
sector middle 0.12
FY24 0.17FY26 0.32
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 22% of 59 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+32.9%
Higher than 78% of 46 peers
sector middle +14.9%

Peers are the listed companies in the exchange's own industry group: Pharmacy Retail. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.4.0%FY26Profit YoYHow much net profit grew in the latest quarter against the same quarter a year earlier.+66.0%latest quarterSalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹6,591 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹146 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹2.2 as profit.

Where it wentPer ₹100 of sales
Running costs₹96.0Depreciation₹0.7Interest₹0.8Tax₹0.5Profit₹2.2

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales--+32.9%
Profit--+66.0%
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹83 Cr, after ₹68 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹96 Cr
Investing-₹303 Cr
Lenders and shareholders+₹124 Cr
Net change in cash-₹83 Cr
Operating cash per ₹100 of profit
₹-92FY24₹-72FY25₹66FY26
₹100 or more means the reported profit arrived as cash.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.3.4%4.0%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.2.1%2.2%
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.6.3%8.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.9.1%10.7%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.17x0.32x
Interest coverHow many times the company's profit before interest could pay its interest bill.4.3x4.3x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · ENTEROStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTEROPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTEROBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTERO52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on ENTERO
Backtest idea · ENTEROGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on ENTERO
MACD momentum on ENTEROBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on ENTEROBuy when closes below the lower Bollinger band
Supertrend rider on ENTEROBuy when supertrend turns up
Buy the dip on ENTEROBuy when RSI(14) drops below 30
52-week high breakout on ENTEROBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Retailing
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
ETERNAL
ETERNAL LIMITED
3.54 L cr679.4x11.3x1.2%3.3%0.000.6%+77.6%0.00%
DMART
Avenue Supermarts Limited
2.28 L cr73.2x8.8x12.9%17.2%0.164.2%+17.8%0.00%
TRENT
Trent Limited
1.72 L cr90.7x22.1x27.1%35.1%0.068.7%+21.9%0.12%
LENSKART
Lenskart Solutions Limited
1.29 L cr163.7x13.8x5.7%9.5%0.027.7%+35.7%0.00%
MEESHO
Meesho Limited
1.20 L cr-28.5x-30.9%-27.4%0.00-6.2%-0.00%
NYKAA
FSN E-Commerce Ventures Limited
1.02 L cr319.5x61.9x14.3%19.6%0.582.9%+28.1%0.00%
NAUKRI
Info Edge (India) Limited
75,068 cr42.5x1.6x4.6%5.6%0.0063.7%+12.2%0.98%
SWIGGY
Swiggy Limited
50,597 cr-3.0x-29.1%-27.6%0.00-13.3%+36.1%0.00%
VMM
Vishal Mega Mart Limited
43,096 cr47.9x5.5x12.2%18.8%0.006.5%+14.0%0.00%
URBANCO
Urban Company Limited
27,150 cr-13.7x-10.9%-6.1%0.00-24.4%+41.4%0.00%
CARTRADE
Cartrade Tech Limited
12,843 cr54.8x4.9x9.8%12.2%0.0030.8%+10.2%0.00%
MANYAVAR
Vedant Fashions Limited
11,371 cr29.4x5.4x20.0%29.4%0.0026.4%+2.4%1.66%
INDIAMART
Indiamart Intermesh Limited
9,337 cr18.6x4.0x20.7%30.8%0.0030.4%+9.6%3.86%
ABLBL
Aditya Birla Lifestyle Brands Limited
9,305 cr44.9x6.5x12.1%26.0%0.862.3%+11.2%0.66%
FIRSTCRY
Brainbees Solutions Limited
9,119 cr-1.9x-3.8%-0.2%0.15-1.6%+14.1%0.00%
ENTERO
Entero Healthcare Solutions Limited
8,587 cr61.6x4.8x8.3%10.7%0.422.5%+32.9%0.00%
MEDPLUS
Medplus Health Services Limited
7,124 cr33.6x3.4x11.8%21.3%0.002.8%+21.3%0.00%
AVL
Aditya Vision Limited
6,978 cr50.1x9.1x18.4%20.8%0.384.7%+28.1%0.23%
VMART
V-Mart Retail Limited
6,189 cr47.3x6.3x14.1%22.9%0.193.1%+18.1%0.13%
V2RETAIL
V2 Retail Limited
5,738 cr31.0x6.0x26.0%38.5%0.555.0%+27.8%0.00%
JUSTDIAL
Just Dial Limited
5,631 cr11.0x1.1x10.2%12.9%0.0038.3%+13.1%0.00%
EMIL
Electronics Mart India Limited
5,325 cr23.1x3.0x6.8%11.8%0.392.8%+19.4%0.00%
SSRETAIL
SS Retail Limited
4,923 cr-8.0x--0.43--0.00%
ARVINDFASN
Arvind Fashions Limited
4,876 cr37.3x5.0x15.8%26.6%0.563.5%+10.0%0.44%
ABFRL
Aditya Birla Fashion and Retail Limited
4,470 cr-0.9x-12.7%-5.1%0.42-11.0%+2.4%0.00%
SHOPERSTOP
Shoppers Stop Limited
4,156 cr-14.7x-11.8%39.8%1.03-0.2%+8.7%0.00%
STYLEBAAZA
Baazar Style Retail Limited
3,990 cr-7.1x11.0%20.2%0.93-1.9%-10.0%0.00%
PERNIASPOP
Purple Style Labs Limited
3,961 cr-9.4x--0.93--0.00%
RTNINDIA
RattanIndia Enterprises Limited
3,410 cr-4.5x-19.6%-1.58-3.7%-2.9%0.00%
CRIZAC
Crizac Limited
2,634 cr12.6x3.9x37.0%48.4%0.0021.3%-36.7%7.97%
GOCOLORS
Go Fashion (India) Limited
1,512 cr36.6x2.1x8.5%18.5%0.004.9%-2.9%0.00%
KALAMANDIR
Sai Silks (Kalamandir) Limited
1,381 cr10.4x1.1x11.8%17.1%0.017.8%-2.3%1.67%
ACEVECTOR
AceVector Limited
1,109 cr-3.5x--0.10--0.00%
MATRIMONY
Matrimony.Com Limited
1,077 cr18.8x4.6x15.3%21.6%0.0011.7%+17.6%0.96%
TCC
TCC Concept Limited
957 cr-0.6x3.9%4.6%0.00--0.00%
PATELRMART
Patel Retail Limited
769 cr18.6x2.0x10.7%13.3%0.273.3%+34.2%0.00%
MUFTI
Credo Brands Marketing Limited
488 cr9.4x1.1x11.2%21.0%0.008.3%+15.6%2.68%
KORE
Jay Jalaram Technologies Limited
317 cr21.9x3.4x-13.3%1.201.3%+83.7%0.00%
SHANKARA
Shankara Building Products Limited
278 cr19.0x0.6x0.6%2.7%0.411.0%+31.3%0.00%
MAGSON
Magson Retail And Distribution Limited
239 cr94.9x2.5x-3.7%0.121.0%+92.8%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
+7.6
-6.6
+20.9
-2.5
-1.7
-0.5
+4.5
+45.5
-5.6
-7.8
+25.3
·
+92.2%
11m
2025
-5.3
-6.2
-10.1
+15.6
-8.7
-4.5
+12.2
-8.1
-5.7
-0.8
-3.9
-3.4
-27.9%
2024
·
·
-8.8
+18.6
-12.2
+1.1
+15.0
+14.4
-0.2
+0.9
-1.8
+5.3
+31.5%
10m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-09-18HDFC MUTUAL FUND · blockBUY13,90,000₹1,695.00₹235.60 Cr
2026-09-18HDFC MUTUAL FUND · bulkBUY13,90,000₹1,695.00₹235.60 Cr
2026-09-18PRASID UNO FAMILY TRUST · bulkSELL12,21,820₹1,695.00₹207.10 Cr
2026-09-18PRASID UNO FAMILY TRUST · blockSELL12,21,820₹1,695.00₹207.10 Cr
2026-09-18PRASID UNOFAMILY TRUST · blockSELL1,68,180₹1,695.00₹28.51 Cr
2026-09-17PRASID UNO FAMILY TRUST · bulkSELL4,10,000₹1,692.98₹69.41 Cr
2024-02-16MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulkSELL2,22,732₹1,188.51₹26.47 Cr
2024-02-16MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulkBUY2,22,732₹1,180.30₹26.29 Cr
Annual reports

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test ENTERO. “Buy ENTERO when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free